What is MOTS-C? A Complete Guide to MOTS-C Research

MOTS-C is one of the latest mitochondrial-derived research peptides being investigated with growing interest in metabolism, mitochondrial signaling, exercise science, skeletal muscle, and aging studies. It should be noted that what makes MOTS-C unique is its mode of production; while the vast majority of peptides are encoded within nuclear DNA, MOTS-C is produced from mitochondrial DNA.

MOTS-C was first characterized by Lee et al. (2015), who investigated its potential role in metabolic regulation and insulin sensitivity.

At present, the studies of MOTS-C are being extended from cell culture and animal studies to human studies, thus enhancing the significance of the peptide for metabolic and mitochondrial laboratories.

What is MOTS-C Peptide?

Mitochondrial open reading frame of the 12S rRNA type-c is abbreviated as MOTS-C and refers to a natural 16-amino acid peptide derived from the mitochondrion. It is encoded by a short open reading frame in the mitochondrial 12S ribosomal RNA gene region.

The discovery of MOTS-C provided evidence that mitochondria can encode and produce signaling peptides that can affect cellular and systemic metabolism. Lee et al. (2015) reported that skeletal muscle appeared to be a primary target tissue for MOTS-C and that MOTS-C influences metabolic pathways involving the folate cycle, purine biosynthesis, and AMPK signaling. Moreover, the experiments revealed the effects of MOTS-C on the sensitivity of cells to insulin and diet-induced metabolism in mice.

MOTS-C is classified under the larger category of mitochondrial-derived peptides (MDPs). The mitochondrial origin of MOTS-C, coupled with the putative function in metabolic signaling, explains its significance to current scientific investigations.

MOTS-C Research Profile

Characteristic	MOTS-C
Peptide class	Mitochondrial-derived peptide
Peptide length	16 amino acids
Genetic origin	Mitochondrial DNA
Encoded region	12S rRNA / MT-RNR1
Primary research areas	Metabolism, mitochondrial signaling, exercise, aging
Key pathway investigated	AMPK and metabolic signaling
Research status	Investigational
Intended context	Research Use Only (RUO)

How Does MOTS-C Work?

One of the best-characterized proposed mechanisms of MOTS-C involves the folate cycle, de novo purine biosynthesis, AICAR, and AMPK signaling.

Lee et al. (2015) showed that MOTS-C had an effect on some parts of the folate cycle and the associated pathway of de novo purine biosynthesis, leading to an increase in AICAR production. Since AICAR can activate AMP-activated protein kinase (AMPK), the scientists suggested that this particular pathway could contribute to the observed metabolic effects of MOTS-C. Moreover, the experiments revealed changes in glucose and fatty acid metabolism in cell and animal studies.

Apart from this, MOTS-C was studied as a possible mitochondrial-to-nuclear signaling molecule. In the case of metabolic stress, MOTS-C has been shown to affect the expression of certain nuclear genes and signaling pathways involved in adaptation.

Such a combination of mitochondrial origin and metabolic signaling makes MOTS-C especially attractive in energy metabolism-related studies.

MOTS-C and Metabolic Research

Glucose metabolism and insulin sensitivity were among the earliest areas to demonstrate the usefulness of MOTS-C. Lee et al. (2015) showed the ability of MOTS-C administration to improve glucose tolerance and protect mice from diet-induced insulin resistance and obesity.

Observational studies in humans have further contributed to the evidence supporting a potential application area of MOTS-C. Du et al. (2018) found decreased plasma MOTS-C in obese boys and adolescents and correlations between MOTS-C and BMI, fasting insulin, HOMA-IR, and HbA1c. However, as this was an observational study, the results can only suggest an association but not the therapeutic effect of MOTS-C.

Kong et al. (2021) reported that MOTS-C reduced autoimmune β-cell destruction in non-obese diabetic mice and investigated its effects on T-cell metabolism and mTORC1 signaling, suggesting another potential area for MOTS-C research.

Interventional human research is already being conducted in the area. ClinicalTrials.gov NCT07505745 is a phase 2a randomized double-blind placebo-controlled study of investigational MOTS-C in adults with prediabetes and overweight or obesity. The study has an estimated enrollment of 120 participants, and the purpose of the study is to examine insulin sensitivity, metabolism, pharmacodynamics, and safety. According to the most recent record of the study on ClinicalTrials.gov, it is Recruiting, and there are no results available yet.

MOTS-C and Exercise Research

Exercise physiology is another important area of MOTS-C research. Since mitochondria are central in the production of energy and adaptation of the skeletal muscles, scientists have explored the connection between exercise and MOTS-C and the involvement of MOTS-C in exercise signaling.

Reynolds et al. (2021) reported that exercise increased MOTS-C expression in human skeletal muscle and circulating MOTS-C levels. Moreover, in animal experiments, MOTS-C administration also enhanced physical performance in young, middle-aged, and older mice. Also, there were observed effects on skeletal muscle metabolism and expression of nuclear genes, as well as adaptation to metabolic stress.

Such results put MOTS-C as an important experimental target for the study of exercise-induced mitochondrial signaling, muscle metabolism, and physical adaptation.

Nevertheless, the findings in humans appear to be more complex. Alser et al. (2022) reported lower serum MOTS-C levels in professional endurance athletes than in sedentary controls, while MOTS-C concentrations did not differ significantly between low/moderate- and high-endurance athlete groups.

MOTS-C and Aging Research

MOTS-C has generated great interest in aging studies due to the connection between mitochondrial functioning, metabolic flexibility, cellular stress responses, and physical performance with physiological aging. Thus, according to Reynolds et al. (2021), MOTS-C administration enhanced physical performance in young, middle-aged, and old mice and affected molecular pathways involved in the functioning of skeletal muscle metabolism and homeostasis, suggesting that MOTS-C could play a role in physiological adaptations to aging.

Furthermore, Kim et al. (2018) have shown that MOTS-c is capable of moving from mitochondria to the nucleus as a response to metabolic stress and regulating the expression of nuclear genes through the AMPK pathway. Moreover, the researchers observed interactions between MOTS-c and stress-responsive transcription factors such as NRF2, providing evidence for possible participation of MOTS-c in cellular stress response.

Thus, the results obtained have made MOTS-C an interesting object of research regarding the relationship between mitochondrial signaling, metabolic stress, skeletal muscle functioning, and physiological aging.

Why is MOTS-C Important for Research?

For scientists, the availability of MOTS-C allows the examination of a peptide that is derived from the mitochondrial DNA itself. The potential significance of the peptide for metabolic signaling, AMPK modulation, adaptation to exercise, and mitochondrial-nuclear signaling makes it valuable for scientific research in different fields.

The current directions of research on MOTS-C can be summarized as follows:

• Mitochondrial-derived peptides biology
• AMPK and cellular energy signaling
• Glucose and insulin sensitivity
• Skeletal muscle metabolism
• Exercise physiology
• Cellular stress signaling
• Metabolic aging
• Mitochondrial-nuclear signaling
• Metabolic disease animal models

A MOTS-C research peptide provides scientists with an experimental subject for studying mitochondrial signaling, metabolism, and energy regulation.

Current MOTS-C Research and Human Studies

At present, most of the studies done on MOTS-C are preclinical, involving mostly cell and animal models. Human-based studies have also been carried out with respect to MOTS-C in the blood, obesity, insulin resistance, exercise, and many other physiological variables.

The MOTS-MET Phase 2a trial represents an important step toward evaluating native MOTS-C in humans. The study is designed to evaluate whether investigational MOTS-C affects insulin sensitivity and related metabolic outcomes while monitoring safety.

Researchers should also distinguish native MOTS-C from CB4211, an investigational analog that has been evaluated separately. Results involving a MOTS-C analog should not automatically be interpreted as clinical evidence for native MOTS-C.

For this reason, MOTS-C remains best positioned as an investigational research peptide, with its mechanisms and potential research applications continuing to be evaluated.

FAQs

Q1. What is MOTS-C?

MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial genome. Lee et al. (2015) first characterized the peptide and reported its involvement in metabolic regulation.

Q2. What are the applications of MOTS-C in research?

MOTS-C has been studied in mitochondrial signaling, metabolism, insulin sensitivity, AMPK activation, skeletal muscle, adaptation to exercise, and aging.

Q3. How does MOTS-C work?

Lee et al. (2015) revealed that MOTS-C regulates the pathways of folate and purine biosynthesis and enhances the concentration of AICAR, thus revealing the mechanism underlying AMPK activation and metabolism.

Q4. What does research on MOTS-C show about exercise?

Reynolds et al. (2021) studied the role of MOTS-C in exercise-induced adaptations in humans and animal models of skeletal muscles.

Q5. Is MOTS-C being studied in humans?

Yes. Human observational research has examined endogenous MOTS-C, and NCT07505745 is currently evaluating administered native MOTS-C in a Phase 2a randomized, placebo-controlled study. No results have been posted to date.

Q6. Is MOTS-C FDA-approved?

It is an investigational research peptide that is not FDA-approved for any treatment purpose. All research products must have the Research Use Only (RUO) label since these are not supposed to be taken by humans.

Q7. What are the potential research benefits of MOTS-C?

MOTS-C has been studied to explore its role in metabolic regulation, AMPK activation, glucose metabolism, exercise physiology, muscle biology, cellular stress, and aging. However, the results depend on experimental models, and a lot of them have yet to be confirmed clinically.

Conclusion

MOTS-C has emerged as a distinctive research target within the growing field of mitochondrial-derived peptides and metabolism because of its unique genetic background and potential involvement in cell energy regulation. According to Lee et al. (2015), MOTS-C has been studied by Reynolds et al. (2021), Du et al. (2018), Kim et al. (2018), Kong et al. (2021), and others in fields such as metabolism, insulin resistance, exercise science, muscle biology, stress biology, and aging.

Research focus is now moving towards human studies in a controlled environment. An important step in this direction is the MOTS-MET Phase 2a trial that will evaluate the effects of native MOTS-C on patients with prediabetes and overweight/obesity.

For laboratories investigating mitochondrial-derived peptides, AMPK signaling, metabolism, exercise physiology, and aging biology, MOTS-C represents a distinctive and increasingly studied research target.

References

1. Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., … & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443-454.
2. Du, C., Zhang, C., Wu, W., Liang, Y., Wang, A., Wu, S., … & Luo, X. (2018). Circulating MOTS‐c levels are decreased in obese male children and adolescents and associated with insulin resistance. Pediatric diabetes, 19(6), 1058-1064.
3. Reynolds, J. C., Lai, R. W., Woodhead, J. S., Joly, J. H., Mitchell, C. J., Cameron-Smith, D., … & Lee, C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature communications, 12(1), 470.
4. Alser, M., Ramanjaneya, M., Anwardeen, N. R., Donati, F., Botrè, F., Jerobin, J., … & Elrayess, M. A. (2022). The effect of chronic endurance exercise on serum levels of MOTS-c and humanin in professional athletes. Reviews in Cardiovascular Medicine, 23(5), 181.
5. Kim, K. H., Son, J. M., Benayoun, B. A., & Lee, C. (2018). The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism, 28(3), 516-524.
6. Kong, B. S., Min, S. H., Lee, C., & Cho, Y. M. (2021). Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes. Cell Reports, 36(4).
7. ClinicalTrials.gov. (2026). NCT07505745: MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity (MOTS-MET). Recruiting; no results posted.